1[1]Chakaravarthy U, Hayes RG, Stitt AW, et al. Constitutive nitric oxide synthase expression in retinal vascular endothelial cell is suppressed by high glucose and advanced glycation end products. Diabetes, 1998; 47(6):945.
2[2]Pfeifer MA, Schumer MP, Gelber DA. Aldose reductase inhibitors: The end of an era of the need for different trial design. Diabetes, 1997; 46(Suppl 2):S82.
3[3]Rabini RA, Staffolani R, Fumelli P, et al. Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients. Diabetologia, 1998; 41(1):101.
4[4]Harmon JS, Gleason CE, Tanaka Y, et al. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes, 1999; 48(10):1995.
5[5]Roche E, Maestre I, Martin F, et al. Nutrient toxicity in pancreatic beta-cell dysfunction. J Physiol Biochem, 2000; 56(2):119.
6[6]Briaud I, Rouault C, Baibe D, et al. Glucose-induced insulin mRNA accumulation is impaired in islets from neonatal streptozotocn-treated rats. Horm Metab Res, 2000; 32(2):103.
7[1]Yki Jarviner H. Pathogenesis of non - insulin dependent diabetes mellitus[J]. Lancet, 1994,343,91.
8[2]World Health Organization:Definition,Diagnosis and Classification of Diabetes Mellitus and Its Complications: Part 1: Report of a WHO Consultation: Diagnosis and Classification of Diabetes Mellitus[J]. Geneva,World Healt Org, 1999.
9[4]Mathews DR,Hosker JP,Rudenski AS,et al .Homeostasis model assess ment: insulin resistance and beta - cell function from fasting plasma glucose and insulin concentration in man[J] .Diabetologia, 1985,28:412.
10[5]Coutant R, Carel JC,Timsit J, et al. Insulin and the prevention of insulindependent diabetes mellitus[J]. Diabetes Metab, 1997,23(Suppl 3): 25.
